Question 1

Am I eligible for this trial based on my current health and cancer status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT03088540). Contact the study team or your healthcare provider for specific answers.

Question 2

How does cemiplimab compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT03088540). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of cemiplimab compared to standard chemotherapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT03088540). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT03088540). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will be done during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT03088540). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any additional requirements or commitments if I join this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT03088540). Contact the study team or your healthcare provider for specific answers.

What this study is about